Company · CIK 1595893
Turning Point Therapeutics, Inc.
| CIK | 1595893 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-05-31 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-238300 | 2020-05-15 | 2022-08-22 | 7 | |
| 333-233602 | 2019-09-03 | 2019-09-06 | 3 | |
| 333-230428 | 2019-03-21 | 2019-04-18 | 6 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-08-22 | EFFECTDeclared effective | 333-238300 | 9999999995-22-002458 |
| 2020-10-27 | 424B5Shelf takedown | 333-238300 | 0001193125-20-278443 |
| 2020-10-26 | 424B5Shelf takedown | 333-238300 | 0001193125-20-276036 |
| 2020-08-10 | 424B5Shelf takedown | 333-238300 | 0001193125-20-214226 |
| 2020-05-19 | 424B5Shelf takedown | 333-238300 | 0001193125-20-146272 |
| 2020-05-18 | 424B5Shelf takedown | 333-238300 | 0001193125-20-144517 |
| 2020-05-15 | S-3ASRShelf registered | 333-238300 | 0001193125-20-143985 |
| 2019-09-06 | 424B4Final prospectus | 333-233602 | 0001193125-19-239963 |
| 2019-09-05 | EFFECTDeclared effective | 333-233602 | 9999999995-19-002030 |
| 2019-09-03 | S-1Registration filed | 333-233602 | 0001193125-19-236511 |
| 2019-08-19 | DRSDraft made public | 377-02803 | 0000950123-19-008571 |
| 2019-04-18 | 424B4Final prospectus | 333-230428 | 0001193125-19-109835 |
| 2019-04-16 | EFFECTDeclared effective | 333-230428 | 9999999995-19-000732 |
| 2019-04-16 | S-1/AAmendment | 333-230428 | 0001193125-19-107113 |
| 2019-04-12 | S-1/AAmendment | 333-230428 | 0001193125-19-104461 |
| 2019-04-08 | S-1/AAmendment | 333-230428 | 0001193125-19-099845 |
| 2019-03-21 | S-1Registration filed | 333-230428 | 0001193125-19-082317 |
| 2019-02-14 | DRSDraft made public | 377-02515 | 0000950123-19-002236 |